Systematic Functional Interrogation of Genes in GWAS Loci Identified ATF1 As a Key Driver in Colorectal Cancer Modulated by a Promoter-Enhancer Interaction.
Jianbo Tian,Jiang Chang,Jing Gong,Jiao Lou,Mingpeng Fu,Jiaoyuan Li,Juntao Ke,Ying Zhu,Yajie Gong,Yang,Danyi Zou,Xiating Peng,Nan Yang,Shufang Mei,Xiaoyang Wang,Rong Zhong,Kailin Cai,Xiaoping Miao
DOI: https://doi.org/10.1016/j.ajhg.2019.05.004
2019-01-01
The American Journal of Human Genetics
Abstract:Genome-wide association studies (GWASs) have identified approximately 100 colorectal cancer (CRC) risk loci. However, the causal genes in these loci have not been systematically interrogated. We conducted a high-throughput RNA-interference functional screen to identify the genes essential for proliferation in the CRC risk loci of Asian populations. We found that ATF1, located in the 12q13.12 region, functions as an oncogene that facilitates cell proliferation; ATF1 has the most significant effect of the identified genes and promotes CRC xenograft growth by affecting cell apoptosis. Next, by integrating a fine-mapping analysis, a two-stage affected-control study consisting of 6,213 affected individuals and 10,388 controls, and multipronged experiments, we elucidated that two risk variants, dbSNP: rs61926301 and dbSNP: rs7959129, that located in the ATF1 promoter and first intron, respectively, facilitate a promoter-enhancer interaction, mediated by the synergy of SP1 and GATA3, to upregulate ATF1 expression, thus synergistically predisposing to CRC risk (OR = 1.77, 95% CI = 1.42-2.21, p = 3.16 x 10(-7); Pmultiplicative-interaction = 1.20 x 10(-22); Padditive-interaction = 6.50 x 10(-3)). Finally, we performed RNA-seq and ChIP-seq assays in CRC cells treated with ATF1 overexpression in order to dissect the target programs of ATF1. Results showed that ATF1 activates a subset of genes, including BRAF, NRAS, MYC, BIRC2, DAAM1, MAML2, STAT1, ID1, and NKD2, related to apoptosis, Wnt, TGF-beta, and MAPK pathways, and these effects could cooperatively increase the risk of CRC. These findings reveal the clinical potential of ATF1 in CRC development and illuminate a promoter-enhancer interaction module between the ATF1 regulatory elements dbSNP: rs61926301 and dbSNP: rs7959129, and they bring us closer to understanding the molecular drivers of cancer.